A carregar...

Pentamethylmelamine (PMM): Phase I clinical and pharmacokinetic studies.

PMM is a water-soluble alternative to HMM. PMM has been administered as an intravenous infusion to 17 patients in a Phase I clinical trial. The dose-limiting toxicities were nausea and vomiting which were observed in all patients at 500 mg m-2 and above. The dose was not escalated above 1300 mg m-2...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Muindi, J. R., Newell, D. R., Smith, I. E., Harrap, K. R.
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 1983
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2011259/
https://ncbi.nlm.nih.gov/pubmed/6401427
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!